Ipca Laboratories, 524494, IPCALAB Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

44,825.73
39.28
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

44,965.08
0.34%
5.56

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.77
10.61
7.80

EBITDA CAGR (%)

10 Years
5 Years
3 Years

16.75
9.22
9.11

PAT CAGR (%)

10 Years
5 Years
3 Years

19.43
4.88
27.54

P:E (Median)

8 Years
5 Years
3 Years

37.30
43.10
50.01

P:BV (Average)

8 Years
5 Years
3 Years

4.79
4.75
5.02

EV:EBITDA (Average)

8 Years
5 Years
3 Years

20.20
20.80
22.21

Earnings Forecasts:

(Updated: 01-08-2026)

Description 2026 2027 2028 2029
Adj EPS 73 6 21.03 43.54
P/E Ratio 24.18 294.17 83.93 40.54
Revenue 31.84 26.96 22.2 9660.66
EBITDA 10750.9 12000.1 13298.5 1983.28
Net Income 2378.93 2739.44 3115.76 1121.73
ROA 1403.74 1665.25 1965 9.05
P/B Ratio -2.26 -0.99 -0.63 5.67
ROE 4.59 3.95 3.36 14.45
FCFF 15.29 15.62 15.81 875.11
FCFF Yield 904.57 1100.37 4427.74 1.96
Net Debt 2.02 2.46 9.91 565.6
BVPS -782.43 -1781.44 -2805.1 311.13

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 1,814.35 1,638.44 10.74% 1,845.18 1,662.68 10.98% 1,930.32 1,810.94 6.59% 1,746.90 1,565.86 11.56%
Expenses 1,383.17 1,279.85 8.07% 1,367.70 1,251.59 9.28% 1,465.61 1,408.83 4.03% 1,339.98 1,212.62 10.50%
EBITDA 431.18 358.59 20.24% 477.48 411.09 16.15% 464.71 402.11 15.57% 406.92 353.24 15.20%
EBIDTM 23.77% 21.89% 25.88% 24.72% 24.07% 22.20% 23.29% 22.56%
Other Income 29.88 21.49 39.04% 17.82 17.41 2.35% 21.92 17.00 28.94% 25.02 15.39 62.57%
Interest 10.48 16.20 -35.31% 9.51 10.17 -6.49% 11.46 17.25 -33.57% 12.06 19.42 -37.90%
Depreciation 70.31 65.19 7.85% 68.57 62.81 9.17% 66.86 62.65 6.72% 63.13 61.32 2.95%
PBT 349.85 17.15 1,939.94% 417.22 355.52 17.35% 408.31 339.21 20.37% 356.75 287.89 23.92%
Tax 87.56 82.20 6.52% 113.77 87.96 29.34% 103.57 95.09 8.92% 94.71 83.76 13.07%
PAT 262.29 -65.05 - 303.45 267.56 13.41% 304.74 244.12 24.83% 262.04 204.13 28.37%
PATM 14.46% -3.97% 16.45% 16.09% 15.79% 13.48% 15.00% 13.04%
EPS 10.34 -2.56 - 11.96 10.55 13.36% 12.01 9.62 24.84% 10.33 8.05 28.32%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 2,388.48 2,246.69 6.31% 2,392.50 2,245.37 6.55% 2,556.50 2,354.90 8.56% 2,308.85 2,092.63 10.33%
Expenses 1,904.61 1,817.83 4.77% 1,859.15 1,782.29 4.31% 2,011.58 1,913.42 5.13% 1,892.43 1,699.91 11.33%
EBITDA 483.87 428.86 12.83% 533.35 463.08 15.17% 544.92 441.48 23.43% 416.42 392.72 6.03%
EBIDTM 20.26% 19.09% 22.29% 20.62% 21.32% 18.75% 18.04% 18.77%
Other Income 93.74 25.82 263.05% 20.19 20.11 0.40% 27.86 26.26 6.09% 32.66 20.61 58.47%
Interest 20.20 21.51 -6.09% 17.62 16.81 4.82% 19.61 22.56 -13.08% 18.51 24.05 -23.04%
Depreciation 107.14 100.12 7.01% 107.59 98.46 9.27% 103.33 100.35 2.97% 100.06 98.89 1.18%
PBT 404.45 128.00 215.98% 445.98 367.92 21.22% 391.58 344.83 13.56% 330.51 290.39 13.82%
Tax 95.05 62.22 52.76% 81.93 90.59 -9.56% 108.08 99.39 8.74% 96.09 91.41 5.12%
PAT 309.40 65.78 370.36% 364.05 277.33 31.27% 283.50 245.44 15.51% 234.42 198.98 17.81%
PATM 12.95% 2.93% 15.22% 12.35% 11.09% 10.42% 10.15% 9.51%
EPS 11.79 2.67 341.57% 12.86 9.78 31.49% 11.14 9.05 23.09% 9.19 7.58 21.24%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales - 7,289.49 6,635.38 6,124.06 5,774.72 5,405.42 5,114.11 4,337.82 3,605.66 3,193.40 3,102.21 Net Sales Growth - 9.86% 8.35% 6.05% 6.83% 5.70% 17.90% 20.31% 12.91% 2.94% Cost Of Goods Sold - 1,608.30 1,673.19 1,722.87 1,843.06 1,562.85 1,402.41 1,292.23 1,010.36 966.04 936.63 Gross Profit - 5,681.19 4,962.19 4,401.19 3,931.66 3,842.57 3,711.70 3,045.59 2,595.30 2,227.36 2,165.58 GP Margin - 77.94% 74.78% 71.87% 68.08% 71.09% 72.58% 70.21% 71.98% 69.75% 69.81% Total Expenditure - 5,534.49 5,145.54 4,959.25 4,886.60 4,220.01 3,663.90 3,439.48 2,926.87 2,766.48 2,703.54 Power & Fuel Cost - 250.97 235.60 253.33 277.21 237.44 201.48 196.82 175.25 159.89 148.93 % Of Sales - 3.44% 3.55% 4.14% 4.80% 4.39% 3.94% 4.54% 4.86% 5.01% 4.80% Employee Cost - 1,655.90 1,479.34 1,336.19 1,193.39 1,102.14 948.84 870.79 752.24 712.78 674.93 % Of Sales - 22.72% 22.29% 21.82% 20.67% 20.39% 18.55% 20.07% 20.86% 22.32% 21.76% Manufacturing Exp. - 761.69 692.10 709.68 626.15 588.03 501.49 449.83 363.05 359.41 400.11 % Of Sales - 10.45% 10.43% 11.59% 10.84% 10.88% 9.81% 10.37% 10.07% 11.25% 12.90% General & Admin Exp. - 314.04 290.82 284.69 271.90 239.62 223.46 233.95 261.02 262.26 237.93 % Of Sales - 4.31% 4.38% 4.65% 4.71% 4.43% 4.37% 5.39% 7.24% 8.21% 7.67% Selling & Distn. Exp. - 784.22 695.43 592.49 574.87 399.49 323.91 355.23 317.80 275.05 281.33 % Of Sales - 10.76% 10.48% 9.67% 9.95% 7.39% 6.33% 8.19% 8.81% 8.61% 9.07% Miscellaneous Exp. - 159.37 79.06 60.00 100.02 90.44 62.31 40.63 47.15 31.05 281.33 % Of Sales - 2.19% 1.19% 0.98% 1.73% 1.67% 1.22% 0.94% 1.31% 0.97% 0.76% EBITDA - 1,755.00 1,489.84 1,164.81 888.12 1,185.41 1,450.21 898.34 678.79 426.92 398.67 EBITDA Margin - 24.08% 22.45% 19.02% 15.38% 21.93% 28.36% 20.71% 18.83% 13.37% 12.85% Other Income - 121.88 108.50 159.77 137.34 108.76 128.60 84.16 71.57 57.70 56.52 Interest - 45.46 65.06 122.58 46.34 10.41 11.13 18.84 21.09 27.46 25.99 Depreciation - 268.87 251.97 246.48 228.63 209.65 187.72 178.69 171.88 174.36 171.00 PBT - 1,562.55 1,281.31 955.52 750.49 1,074.11 1,379.96 784.97 557.39 282.80 258.20 Tax - 399.61 349.01 291.75 244.79 213.74 239.19 132.51 102.48 49.69 69.91 Tax Rate - 26.08% 34.91% 35.49% 32.62% 19.90% 17.33% 16.88% 18.39% 17.57% 27.08% PAT - 1,132.52 650.76 530.41 505.70 860.37 1,140.77 652.46 454.91 233.11 188.29 PAT before Minority Interest - 1,132.52 650.76 530.41 505.70 860.37 1,140.77 652.46 454.91 233.11 188.29 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 15.54% 9.81% 8.66% 8.76% 15.92% 22.31% 15.04% 12.62% 7.30% 6.07% PAT Growth - 74.03% 22.69% 4.89% -41.22% -24.58% 74.84% 43.43% 95.15% 23.80% EPS - 44.64 25.65 20.91 19.93 33.91 44.97 25.72 17.93 9.19 7.42

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales - 9,599.02 8,896.81 7,662.43 6,204.26 5,796.74 5,394.94 4,619.03 3,745.69 3,257.76 3,156.19 Net Sales Growth - 7.89% 16.11% 23.50% 7.03% 7.45% 16.80% 23.32% 14.98% 3.22% Cost Of Goods Sold - 2,486.16 2,444.61 2,251.73 2,079.50 1,790.78 1,547.98 1,455.41 1,090.34 978.34 939.40 Gross Profit - 7,112.86 6,452.20 5,410.70 4,124.76 4,005.96 3,846.96 3,163.62 2,655.35 2,279.42 2,216.79 GP Margin - 74.10% 72.52% 70.61% 66.48% 69.11% 71.31% 68.49% 70.89% 69.97% 70.24% Total Expenditure - 7,644.55 7,226.28 6,398.38 5,300.99 4,539.12 3,913.71 3,728.56 3,067.42 2,815.78 2,740.77 Power & Fuel Cost - 365.09 351.23 333.97 283.74 242.12 207.10 201.22 176.50 161.92 151.00 % Of Sales - 3.80% 3.95% 4.36% 4.57% 4.18% 3.84% 4.36% 4.71% 4.97% 4.78% Employee Cost - 2,160.20 1,983.99 1,708.43 1,287.64 1,177.39 1,013.57 921.23 787.40 735.88 695.98 % Of Sales - 22.50% 22.30% 22.30% 20.75% 20.31% 18.79% 19.94% 21.02% 22.59% 22.05% Manufacturing Exp. - 1,055.48 966.04 892.99 655.66 610.03 524.21 471.80 374.26 366.92 404.52 % Of Sales - 11.00% 10.86% 11.65% 10.57% 10.52% 9.72% 10.21% 9.99% 11.26% 12.82% General & Admin Exp. - 425.70 387.39 345.05 296.10 261.34 242.22 249.90 271.85 268.52 246.68 % Of Sales - 4.43% 4.35% 4.50% 4.77% 4.51% 4.49% 5.41% 7.26% 8.24% 7.82% Selling & Distn. Exp. - 973.11 917.41 745.87 595.47 402.81 324.86 359.15 317.84 277.62 280.74 % Of Sales - 10.14% 10.31% 9.73% 9.60% 6.95% 6.02% 7.78% 8.49% 8.52% 8.89% Miscellaneous Exp. - 178.81 175.61 120.34 102.88 54.65 53.77 69.85 49.23 26.58 280.74 % Of Sales - 1.86% 1.97% 1.57% 1.66% 0.94% 1.00% 1.51% 1.31% 0.82% 0.71% EBITDA - 1,954.47 1,670.53 1,264.05 903.27 1,257.62 1,481.23 890.47 678.27 441.98 415.42 EBITDA Margin - 20.36% 18.78% 16.50% 14.56% 21.70% 27.46% 19.28% 18.11% 13.57% 13.16% Other Income - 201.69 151.32 184.36 151.77 121.72 129.19 86.50 74.66 58.08 54.76 Interest - 79.09 87.84 140.75 48.19 11.20 12.27 19.77 22.24 27.57 26.91 Depreciation - 418.12 397.82 357.24 261.56 232.42 209.17 210.50 182.42 177.73 172.95 PBT - 1,658.95 1,336.19 950.42 745.29 1,135.72 1,388.98 746.70 548.27 294.76 270.32 Tax - 381.15 343.61 313.46 253.36 224.77 240.14 135.33 104.24 51.11 67.52 Tax Rate - 24.24% 30.38% 37.20% 33.99% 19.79% 17.29% 18.12% 19.01% 17.34% 24.98% PAT - 1,148.71 739.97 553.64 484.26 905.24 1,147.71 606.32 445.58 239.42 194.54 PAT before Minority Interest - 1,191.37 787.53 529.21 491.93 910.95 1,148.84 603.56 442.22 239.42 194.54 Minority Interest - -42.66 -47.56 24.43 -7.67 -5.71 -1.13 2.76 3.36 0.00 0.00 PAT Margin - 11.97% 8.32% 7.23% 7.81% 15.62% 21.27% 13.13% 11.90% 7.35% 6.16% PAT Growth - 55.24% 33.66% 14.33% -46.50% -21.13% 89.29% 36.07% 86.11% 23.07% EPS - 45.28 29.17 21.82 19.09 35.68 45.24 23.90 17.56 9.44 7.67

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 7,979.35 6,891.62 6,348.71 5,877.30 5,475.76 4,752.72 3,677.54 3,136.66 2,694.94 2,475.12 Share Capital 25.37 25.37 25.37 25.37 25.37 25.37 25.27 25.27 25.24 25.24 Total Reserves 7,953.98 6,866.25 6,323.34 5,851.93 5,450.39 4,727.35 3,640.33 3,111.39 2,669.38 2,449.88 Non-Current Liabilities 377.40 759.77 790.39 891.89 608.95 191.82 265.43 307.04 420.11 546.49 Secured Loans 70.00 482.43 542.19 651.78 395.18 9.13 64.21 133.94 234.01 347.22 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 14.17 0.00 0.00 4.52 Long Term Provisions 68.58 57.76 50.49 46.57 42.34 37.29 30.98 25.28 25.88 24.55 Current Liabilities 1,418.75 1,417.60 1,520.17 1,677.78 1,353.73 1,065.59 1,241.60 1,013.84 992.65 946.34 Trade Payables 605.55 481.53 422.74 450.84 491.95 526.46 537.85 464.09 414.75 388.06 Other Current Liabilities 601.45 606.45 586.34 470.42 407.05 278.51 294.88 266.94 262.00 315.35 Short Term Borrowings 2.05 154.95 368.53 626.90 337.58 147.47 309.27 195.86 239.04 177.30 Short Term Provisions 209.70 174.67 142.56 129.62 117.15 113.15 99.60 86.95 76.86 65.63 Total Liabilities 9,775.50 9,068.99 8,659.27 8,446.97 7,438.44 6,010.13 5,184.57 4,457.54 4,107.70 3,967.95 Net Block 2,969.35 2,536.97 2,523.70 2,478.66 2,153.09 1,868.60 1,840.97 1,740.10 1,854.61 1,945.97 Gross Block 5,055.87 4,387.79 4,157.07 3,880.12 3,370.69 2,888.47 2,679.08 2,412.97 2,358.72 2,276.99 Accumulated Depreciation 2,086.52 1,850.82 1,633.37 1,401.46 1,201.76 1,004.03 838.11 672.87 504.11 331.02 Non Current Assets 5,780.50 5,252.87 5,149.38 3,571.82 3,203.52 2,732.34 2,472.46 2,171.99 2,200.54 2,256.30 Capital Work in Progress 459.37 489.65 175.20 123.02 297.15 182.00 84.19 65.96 73.23 94.87 Non Current Investment 2,188.39 2,041.32 2,243.56 733.41 619.39 474.01 410.47 231.86 146.28 98.01 Long Term Loans & Adv. 142.19 164.40 186.16 227.77 119.21 183.45 125.65 128.11 119.19 105.98 Other Non Current Assets 21.20 20.53 20.76 8.96 14.68 24.28 11.18 5.96 7.23 11.47 Current Assets 3,995.00 3,779.94 3,509.89 4,875.15 4,224.46 3,277.79 2,712.11 2,285.55 1,907.16 1,711.65 Current Investments 348.03 651.94 410.60 323.32 719.31 393.83 238.25 90.38 69.35 113.57 Inventories 1,707.51 1,542.39 1,677.09 1,660.13 1,779.54 1,517.09 1,266.96 1,055.55 873.17 873.54 Sundry Debtors 1,272.05 1,166.37 1,027.40 925.90 824.30 774.46 839.13 632.06 594.38 501.98 Cash & Bank 363.18 164.53 112.92 1,706.06 595.50 306.92 152.40 259.81 131.03 17.53 Other Current Assets 304.23 66.75 99.86 111.10 305.81 285.49 215.37 247.75 239.23 205.03 Short Term Loans & Adv. 245.72 187.96 182.02 148.64 195.08 209.20 94.47 170.23 173.64 134.86 Net Current Assets 2,576.25 2,362.34 1,989.72 3,197.37 2,870.73 2,212.20 1,470.51 1,271.71 914.51 765.31 Total Assets 9,775.50 9,032.81 8,659.27 8,446.97 7,427.98 6,010.13 5,184.57 4,457.54 4,107.70 3,967.95

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 8,063.81 6,948.45 6,332.19 5,842.02 5,464.84 4,701.65 3,627.48 3,122.39 2,688.57 2,455.26 Share Capital 25.37 25.37 25.37 25.37 25.37 25.37 25.27 25.27 25.24 25.24 Total Reserves 8,035.30 6,920.38 6,305.21 5,816.65 5,439.47 4,676.28 3,590.27 3,097.12 2,663.01 2,430.02 Non-Current Liabilities 518.66 969.14 1,014.41 901.72 613.87 189.69 290.29 313.40 419.42 548.32 Secured Loans 109.12 543.24 580.41 651.78 395.18 9.13 88.80 133.94 234.01 347.22 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 14.17 6.91 0.00 4.52 Long Term Provisions 97.91 96.31 86.84 46.99 42.73 38.56 32.23 25.28 25.88 24.55 Current Liabilities 2,306.93 2,384.29 2,355.64 1,805.82 1,465.88 1,160.54 1,326.42 1,097.50 1,007.57 955.93 Trade Payables 940.29 846.17 776.08 525.06 557.70 664.86 609.85 524.32 423.47 396.54 Other Current Liabilities 732.07 725.45 732.62 488.15 420.52 204.49 304.57 274.74 266.75 316.41 Short Term Borrowings 417.49 495.25 559.24 661.82 367.81 176.61 310.95 209.69 239.04 177.30 Short Term Provisions 217.08 317.42 287.70 130.79 119.85 114.58 101.05 88.75 78.31 65.68 Total Liabilities 12,349.65 11,741.70 11,097.05 8,622.86 7,621.51 6,066.41 5,257.82 4,548.83 4,115.56 3,959.51 Net Block 4,626.89 4,266.81 4,553.53 2,751.38 2,402.19 2,072.43 2,058.73 1,940.38 1,952.96 1,983.27 Gross Block 7,721.79 6,994.56 7,020.79 4,353.42 3,749.46 3,201.39 2,985.73 2,632.86 2,464.33 2,318.22 Accumulated Depreciation 3,094.90 2,727.75 2,467.26 1,602.04 1,331.43 1,113.12 927.00 692.48 511.37 334.95 Non Current Assets 5,972.79 5,475.09 5,558.15 3,433.59 3,164.34 2,629.45 2,402.11 2,171.08 2,170.08 2,217.69 Capital Work in Progress 773.09 621.77 342.89 140.43 306.43 234.82 133.28 66.33 73.00 94.64 Non Current Investment 210.14 216.32 303.61 302.66 269.88 111.43 71.31 30.05 17.52 22.24 Long Term Loans & Adv. 336.37 317.29 315.59 229.61 169.63 185.64 127.61 128.36 119.37 106.07 Other Non Current Assets 26.30 52.90 42.53 9.51 16.21 25.13 11.18 5.96 7.23 11.47 Current Assets 6,373.61 5,967.04 5,535.55 5,189.27 4,446.71 3,436.96 2,855.71 2,377.75 1,945.48 1,741.81 Current Investments 633.42 763.39 558.40 323.32 719.31 393.83 238.25 90.38 69.35 113.57 Inventories 2,731.00 2,560.42 2,471.31 1,743.37 1,857.97 1,594.81 1,323.12 1,072.50 880.59 882.22 Sundry Debtors 2,014.26 1,884.14 1,686.51 989.02 910.78 811.75 895.20 681.51 602.27 500.16 Cash & Bank 564.59 344.23 296.84 1,853.24 640.66 365.07 180.92 282.30 150.57 35.85 Other Current Assets 430.34 120.25 325.01 124.70 317.99 271.50 218.22 251.06 242.70 210.01 Short Term Loans & Adv. 269.57 294.61 197.48 155.62 201.80 193.23 162.29 170.70 174.44 138.60 Net Current Assets 4,066.68 3,582.75 3,179.91 3,383.45 2,980.83 2,276.42 1,529.29 1,280.25 937.91 785.88 Total Assets 12,346.40 11,442.13 11,093.70 8,622.86 7,611.05 6,066.41 5,257.82 4,548.83 4,115.56 3,959.50

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 1,378.12 1,374.07 830.51 762.29 831.72 1,096.06 561.43 495.65 323.86 271.14 PBT 1,532.13 999.77 822.16 750.49 1,074.11 1,379.96 784.97 557.39 282.80 258.20 Adjustment 373.61 605.78 399.16 206.09 221.16 172.50 180.77 174.79 185.03 161.82 Changes in Working Capital -133.68 93.27 -113.86 20.96 -271.39 -214.53 -257.90 -128.87 -86.56 -94.56 Cash after chg. in Working capital 1,772.06 1,698.82 1,107.46 977.54 1,023.88 1,337.93 707.84 603.31 381.27 325.46 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -393.94 -324.75 -276.95 -215.25 -192.16 -241.87 -146.41 -107.66 -57.41 -54.32 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -696.99 -738.81 -1,355.18 -709.61 -814.00 -559.56 -499.13 -122.98 -119.34 -145.55 Net Fixed Assets -637.80 -545.17 -329.13 -335.30 -597.37 -307.20 -284.34 -46.98 -60.09 -105.61 Net Investments 156.84 -39.10 -1,597.43 281.97 -470.86 -219.12 -326.48 -106.61 -4.05 -114.15 Others -216.03 -154.54 571.38 -656.28 254.23 -33.24 111.69 30.61 -55.20 74.21 Cash from Financing Activity -745.21 -428.44 -464.88 506.38 426.04 -307.38 -138.67 -222.83 -130.43 -156.39 Net Cash Inflow / Outflow -64.08 206.82 -989.55 559.06 443.76 229.12 -76.37 149.84 74.09 -30.80 Opening Cash & Equivalents 722.10 515.28 1,504.83 945.77 499.86 272.07 348.44 198.60 124.51 155.31 Closing Cash & Equivalent 658.02 722.10 515.28 1,504.83 945.77 501.19 272.07 348.44 198.60 124.51

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 1,141.97 1,321.32 944.65 805.81 856.07 1,090.13 570.35 501.03 341.13 281.91 PBT 1,572.52 1,131.14 842.67 745.29 1,135.72 1,388.98 738.89 546.46 290.53 262.06 Adjustment 277.35 727.89 489.87 235.18 195.11 183.07 247.37 187.36 192.51 174.86 Changes in Working Capital -293.95 -176.46 -91.59 48.99 -272.72 -236.33 -263.69 -121.97 -84.44 -103.73 Cash after chg. in Working capital 1,555.92 1,682.57 1,240.95 1,029.46 1,058.11 1,335.72 722.57 611.85 398.60 333.19 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -413.95 -361.25 -296.30 -223.65 -202.04 -245.59 -152.22 -110.82 -57.47 -51.28 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -246.77 -869.50 -1,291.79 -725.00 -855.05 -520.69 -509.65 -165.06 -135.40 -148.82 Net Fixed Assets -637.80 -545.17 -329.13 -335.30 -597.37 -307.20 -284.34 -46.98 -60.09 -105.61 Net Investments 156.84 -39.10 -1,597.43 281.97 -470.86 -219.12 -326.48 -106.61 -4.05 -114.15 Others 234.19 -285.23 634.77 -671.67 213.18 5.63 101.17 -11.47 -71.26 70.94 Cash from Financing Activity -753.53 -282.98 -552.55 507.24 426.78 -305.82 -136.54 -183.20 -130.41 -159.13 Net Cash Inflow / Outflow 141.67 168.84 -899.69 588.05 427.80 263.62 -75.84 152.77 75.32 -26.04 Opening Cash & Equivalents 924.63 755.79 1,578.98 990.93 559.01 295.39 370.92 218.15 142.83 168.87 Closing Cash & Equivalent 1,066.30 924.63 755.79 1,578.98 990.93 559.01 295.39 370.92 218.15 142.83

Financial Ratios

Consolidated /

Standalone

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 314.52 271.64 250.24 231.66 215.84 187.34 290.11 248.25 213.52 196.13 ROA 12.02% 7.34% 6.20% 6.37% 12.79% 20.38% 13.53% 10.62% 5.77% 4.78% ROE 15.23% 9.83% 8.68% 8.91% 16.82% 27.10% 19.18% 15.60% 9.02% 7.91% ROCE 19.75% 13.97% 12.78% 11.77% 19.34% 30.54% 20.84% 16.76% 9.53% 8.97% Fixed Asset Turnover 1.55 1.56 1.53 1.60 1.74 1.85 1.72 1.52 1.39 1.43 Receivable days 60.66 59.95 57.81 54.93 53.65 57.30 61.48 61.61 62.15 54.52 Inventory Days 80.84 87.98 98.77 107.96 110.63 98.87 97.05 96.88 99.02 98.55 Payable days 123.36 98.63 88.26 83.21 103.53 123.17 47.09 49.40 50.05 51.96 Cash Conversion Cycle 18.14 49.31 68.31 79.68 60.75 33.00 111.44 109.09 111.12 101.10 Total Debt/Equity 0.03 0.13 0.18 0.24 0.14 0.05 0.12 0.14 0.23 0.29 Interest Cover 34.70 16.37 7.71 17.20 104.18 124.99 42.67 27.43 11.30 10.93

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 317.72 273.78 249.53 230.27 215.41 185.32 286.15 247.12 213.02 194.55 ROA 9.89% 6.90% 5.37% 6.06% 13.31% 20.29% 12.47% 10.25% 6.03% 5.17% ROE 15.88% 11.86% 8.70% 8.70% 17.92% 27.63% 18.15% 15.28% 9.47% 8.60% ROCE 19.41% 15.27% 13.10% 11.71% 20.46% 30.92% 19.92% 16.53% 9.94% 9.44% Fixed Asset Turnover 1.31 1.28 1.35 1.54 1.68 1.75 1.65 1.48 1.37 1.43 Receivable days 73.75 72.89 63.37 55.52 53.92 57.48 61.90 62.09 61.27 53.75 Inventory Days 100.11 102.72 99.83 105.25 108.09 98.25 94.05 94.47 97.98 97.70 Payable days 131.14 121.11 102.19 86.04 111.16 136.39 49.85 51.13 50.35 52.23 Cash Conversion Cycle 42.73 54.51 61.01 74.74 50.86 19.34 106.10 105.43 108.90 99.22 Total Debt/Equity 0.09 0.19 0.22 0.25 0.14 0.05 0.13 0.15 0.23 0.29 Interest Cover 20.88 13.88 6.99 16.47 102.40 114.20 38.77 25.65 11.69 11.05

Top Investors:

hdfc mutual fund

kotak mahindra mutual fund

dsp mutual fund

sbi life insurance co. ltd

nippon india mutual fund

axis mutual fund

hdfc life insurance company limited

edelweiss trusteeship company ltd

kotak funds - india midcap fund

hsbc mutual fund

Annual Reports:

News Update:

Ipca Laboratories inks global licensing agreement with Bhami’s Research Laboratory
15th Jun 2026, 14:10 PM

The company has been granted access to BRL's proprietary high-concentration subcutaneous biologics delivery platform
Read More
Ipca Laboratories - Quarterly Results
30th May 2026, 00:00 AM

Read More

Ipca Laboratories Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524494 | NSE: IPCALAB

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Ipca Laboratories Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524494 | NSE: IPCALAB

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: